THERAGNOSTICS
Theragnostics Ltd was founded in August 2015 to develop and commercialise diagnostic and therapeutic agents. Theragnostics Inc was established in November 2016 to provide a US presence through our office in Boston, MA. Our aim is to provide a complete portfolio of products to transform patient care, from initial diagnosis to therapy, including treatment planning and monitoring. Central to this strategy is the Galliยฎ technology which is revolutionizing PET Gallium-68 diagnostics and radionuclide... therapy. Our most advanced product is THG-001, aka Ga-68 THP-PSMA, which is currently under clinical development. The Galliยฎ technology and the concept of a single step gallium โcoldโ kit, was invented by Prof. Philip Blower and colleagues at Kingโs College London (KCL) and the resultant KCL patent has been granted in US, Japan, Europe and Australia, and is exclusively licensed globally to Theragnostics Ltd.
THERAGNOSTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2015-01-01
Address:
Bracknell, Bracknell Forest, United Kingdom
Country:
United Kingdom
Website Url:
http://www.theragnostics.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)330 606 7437
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Current Employees Featured
Official Site Inspections
http://www.theragnostics.com
- Host name: cloudproxy10118.sucuri.net
- IP address: 192.124.249.118
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago